Polyarticular juvenile rheumatoid arthritis

In 2008, the American College of Rheumatology updated its recommendations for selecting certain rheumatoid arthritis medications. Doctors use these factors to determine the duration of your disease, its severity and your prognosis, which help to develop a treatment plan. What medications you can consider will depend on the severity of your rheumatoid arthritis, the length of time that you've been experiencing signs and symptoms, results from blood tests and X-rays, your overall physical function, and other medical problems you have. Ritixumab has been linked to a fatal brain infection in one person with rheumatoid arthritis. Some people experience extreme reactions to the infusion, such as difficulty breathing and heart problems. For that reason, they may be combined with other medications that give you more immediate relief from signs and symptoms, such as fever, chills and nausea. You may need to take DMARDs for weeks or months before you notice any benefit.